ClinicalTrials.govpublic full text
Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma
neoadjuvant therapy, advanced cancer, metastatic kidney cancer, toripalimab, axitinib, neoadjuvant, advanced/metastatic, non-clear cell renal cell carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 846037
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.